The Endpoint Bubble: Why Clinical Trials Are Drowning in Measurements That Don’t Matter | Cromos Pharma
The Endpoint Bubble: Why Clinical Trials Are Drowning in Measurements That Don’t Matter Why clinical trials collect too many endpoints — and how endpoint bloat obscures study goals instead of improving drug development insights. Read more
Five trends from the ASCO Annual Meeting 2026 | Cromos Pharma
ASCO 2026: Five Trends That Caught My Attention By Vlad Bogin, MD, FACP  CEO, Cromos Pharma  ASCO 2026 delivered thousands of abstracts and countless data points. Beyond individual studies, several broader trends stood out to me as particularly important for the future of oncology and clinical development. Precision Oncology Is Becoming More Precise The industry is moving beyond identifying who should receive a treatment and toward determining who may Read more
Clinical Research Focus. 53rd Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of June 2026. Read more
FSP Model in Clinical Trials — Everything Sponsors Need to Know
FSP Model in Clinical Research: Everything Sponsors Need to Know The FSP model (Functional Service Provider model) has become an increasingly important approach to clinical trial outsourcing, allowing sponsors to access dedicated expertise and resources while maintaining greater control over study operations. Unlike traditional full-service outsourcing, the FSP model enables sponsors to outsource specific functions, teams or capabilities according to their development needs. What Is Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us